« All Events

Stop Spelunking in Health Authority Websites: Using AI for Better Combo Product Intelligence

May 14 @ 12:00 pm – 1:00 pm

Stop Spelunking in Health Authority Websites: Using AI for Better Combo Product Intelligence

Thursday, May 14, 2026 | 12:00 p.m.-1:00 p.m. | Virtual

Register NOW for FREE

Join us virtually for “Stop Spelunking in Health Authority Websites: Using AI for Better Combo Product Intelligence” — a forward-looking session designed to help you streamline your regulatory strategy and make more confident, data-driven decisions.

During this interactive webinar, you’ll discover how AI can transform the way you:

  • Navigate regulatory submission strategies with greater speed and clarity
  • Strengthen risk management approaches across the product lifecycle
  • Design and report Human Factors (HF) studies more efficiently
  • Enable smarter, more proactive post-market surveillance

Whether you’re working in regulatory, clinical, quality or product development, this session will provide practical strategies to reduce complexity, save time and unlock deeper insights.

Shannon Hoste, Founder & Principle Engineer, Hoste Consulting 

Approaching 30 years in medtech and combination products, including a tenure leading Human Factors at FDA’s CDRH, Ms. Hoste specializes in bridging the gap between complex engineering and regulatory approval. Having shaped international standards and FDA guidance, she applies her “both-sides-of-the-table” experience to help teams optimize their path forward using human-centered data.

Ms. Hoste’s focus is on risk-based strategies: ensuring organizations prioritize the activities that yield safe, effective products and seamless regulatory reviews. In this discussion, she’ll explore how modern AI can make the vastness of regulatory data accessible for — frankly — the first time, and how this empowers teams to navigate the modern combination product landscape.

Chetan Mishra, Founder, Rhizome AI 

As the founder of Rhizome AI, Mr. Mishra helps biotechs know what the FDA thinks by making it easy to answer regulatory questions based on product review databases. Each answer references up to 1,000 documents without hallucinations. Previously, Mr. Mishra ran the software team for EvolutionaryScale, a drug discovery company acquired by the Chan Zuckerberg Initiative.

Register today and join us on May 14 to gain the tools you need to stay ahead in an increasingly complex regulatory landscape. Registration is FREE.